Jitka Riedl

Company: Bicycle Therapeutics plc

Job title: Associate Principal Scientist, Project Leader

Seminars:

Bicycle Radionuclide Conjugates Targeting Novel Antigens for Radioisotope Delivery into Solid Tumors 3:30 pm

Outlining the proprietary Bicycle® screening platform can identify novel peptidic binders to complex targets that lack pre-existing peptide-based ligands and then convert these into high affinity and selective Bicycle® molecules Revealing development of Bicycle radionuclide conjugates (BRCs) targeting MT1-MMP and EphA2 Sharing preclinical data from proteins that are widely expressed in a variety of cancers…Read more

day: Conference Day One